2022

1. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

   Frontiers in Medicine, Vol. 9

2. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

   Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736

3. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

   Journal of Clinical Medicine, Vol. 11, Núm. 2

4. Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)

   Journal of Clinical Medicine, Vol. 11, Núm. 24

5. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

   Journal of Clinical Medicine, Vol. 11, Núm. 15